These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12358867)

  • 21. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.
    Lepore G; Bruttomesso D; Nosari I; Tiengo A; Trevisan R
    Diabetes Nutr Metab; 2002 Aug; 15(4):232-9. PubMed ID: 12416660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complications in IDDM are caused by elevated blood glucose level: the Stockholm Diabetes Intervention Study (SDIS) at 10-year follow up.
    Reichard P; Pihl M; Rosenqvist U; Sule J
    Diabetologia; 1996 Dec; 39(12):1483-8. PubMed ID: 8960830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transition from pediatric to adult care. eight years after the transition from pediatric to adult diabetes care: metabolic control, complications and associated diseases.
    Rollo A; Salardi S; Ciavarella A; Forlani G; Scipione M; Maltoni G; Balsamo C; Martini AL; Zucchini S
    J Endocrinol Invest; 2014 Jul; 37(7):653-9. PubMed ID: 24852416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between self-monitoring of blood glucose control and glycosylated haemoglobin in patients with type 2 diabetes with and without diabetic retinopathy.
    Ozmen B; Boyvada S
    J Diabetes Complications; 2003; 17(3):128-34. PubMed ID: 12738396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin adjustment by a diabetes nurse educator improves glucose control in insulin-requiring diabetic patients: a randomized trial.
    Thompson DM; Kozak SE; Sheps S
    CMAJ; 1999 Oct; 161(8):959-62. PubMed ID: 10551191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus.
    Reichard P; Nilsson BY; Rosenqvist U
    N Engl J Med; 1993 Jul; 329(5):304-9. PubMed ID: 8147960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HbA
    Lind M; Pivodic A; Svensson AM; Ólafsdóttir AF; Wedel H; Ludvigsson J
    BMJ; 2019 Aug; 366():l4894. PubMed ID: 31462492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methodology and early findings of the Diabetes Management Project: a cohort study investigating the barriers to optimal diabetes care in diabetic patients with and without diabetic retinopathy.
    Lamoureux EL; Fenwick E; Xie J; Mcauley A; Nicolaou T; Larizza M; Rees G; Qureshi S; Wong TY; Benarous R; Dirani M
    Clin Exp Ophthalmol; 2012; 40(1):73-82. PubMed ID: 21902788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group.
    J Pediatr; 1994 Aug; 125(2):177-88. PubMed ID: 8040759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychosocial factors and complications of IDDM. The Pittsburgh Epidemiology of Diabetes Complications Study. VIII.
    Lloyd CE; Matthews KA; Wing RR; Orchard TJ
    Diabetes Care; 1992 Feb; 15(2):166-72. PubMed ID: 1547672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher risk of microvascular complications in smokers with type 1 diabetes despite intensive insulin therapy.
    Uruska A; Araszkiewicz A; Uruski P; Zozulinska-Ziolkiewicz D
    Microvasc Res; 2014 Mar; 92():79-84. PubMed ID: 24423616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a holistic treatment and teaching programme for patients with Type 1 diabetes who failed to achieve their therapeutic goals under intensified insulin therapy.
    Bott U; Bott S; Hemmann D; Berger M
    Diabet Med; 2000 Sep; 17(9):635-43. PubMed ID: 11051282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus.
    Ak G; Buyukberber S; Sevinc A; Turk HM; Ates M; Sari R; Savli H; Cigli A
    J Diabetes Complications; 2001; 15(3):150-7. PubMed ID: 11358684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial.
    Heller S; White D; Lee E; Lawton J; Pollard D; Waugh N; Amiel S; Barnard K; Beckwith A; Brennan A; Campbell M; Cooper C; Dimairo M; Dixon S; Elliott J; Evans M; Green F; Hackney G; Hammond P; Hallowell N; Jaap A; Kennon B; Kirkham J; Lindsay R; Mansell P; Papaioannou D; Rankin D; Royle P; Smithson WH; Taylor C
    Health Technol Assess; 2017 Apr; 21(20):1-278. PubMed ID: 28440211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating adhesion molecules and associations with HbA1c, hypertension, nephropathy, and retinopathy in the Treatment Options for type 2 Diabetes in Adolescent and Youth study.
    Tryggestad JB; Shah RD; Braffett BH; Bacha F; Gidding SS; Gubitosi-Klug RA; Shah AS; Urbina EM; Levitt Katz LE;
    Pediatr Diabetes; 2020 Sep; 21(6):923-931. PubMed ID: 32501612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Young patients with type 1 diabetes poorly controlled and poorly compliant with self-monitoring of blood glucose: can technology help? Results of the i-NewTrend randomized clinical trial.
    Di Bartolo P; Nicolucci A; Cherubini V; Iafusco D; Scardapane M; Rossi MC
    Acta Diabetol; 2017 Apr; 54(4):393-402. PubMed ID: 28138788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes.
    Yang CY; Su PF; Hung JY; Ou HT; Kuo S
    Cardiovasc Diabetol; 2020 Jul; 19(1):105. PubMed ID: 32631323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.
    Farmer AJ; Wade AN; French DP; Simon J; Yudkin P; Gray A; Craven A; Goyder L; Holman RR; Mant D; Kinmonth AL; Neil HA;
    Health Technol Assess; 2009 Feb; 13(15):iii-iv, ix-xi, 1-50. PubMed ID: 19254484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
    Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
    Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.